Improve Patient And Doctor Engagement With Easy To Use Software For Monitoring Vision Loss.
Vital Art and Science (VAS) developed MyVisionTrack (mVT) – a first of its kind FDA-cleared medical appliance designed to allow patients with age-related macular degeneration or diabetic eye disease to monitor their own vision at home. From home, patients can test their vision, send results to their doctors which would allow doctors to take immediate action when a person’s vision changes. VAS approached Dialexa with a few challenges. Primarily, VAS challenged Dialexa to design a system that would allow physicians to easily track their patients testing, treatments and history. This data would then be used in studies to determine the viability of the test in improving treatment options for patients.
VAS also needed a rebranding of their entire corporate identity and a new website.